NCT03228732View on ClinicalTrials.gov

The Effects of Fluoxetine and/or DHEA

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 19, 2017

Primary Completion Date

September 15, 2026

Study Completion Date

December 15, 2026

Conditions
Type 1 Diabetes Mellitus
Interventions
DRUG

Placebo Oral Tablet

There will be two 2-day inpatient visits with 8-weeks of treatment with placebo between those visits.

DRUG

Placebo Oral Tablet

There will be two 2-day inpatient visits with 8-weeks of treatment with placebo between those visits.

DRUG

Fluoxetine

There will be two 2-day inpatient visits with 8-weeks of treatment with fluoxetine between those visits.

DRUG

DHEA

There will be two 2-day inpatient visits with 8-weeks of treatment with DHEA between those visits.

DRUG

Fluoxetine and DHEA

There will be two 2-day inpatient visits with 8-weeks of treatment with fluoxetine and DHEA between those visits.

Trial Locations (1)

21201

RECRUITING

University of Maryland, Baltimore

All Listed Sponsors
lead

University of Maryland, Baltimore

OTHER